Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ladbury, Colton  [Clear All Filters]
2024
Ladbury C, Sanchez J, Chowdhury A, Palmer J, Liu A, Stein A, Htut M, Farol L, Cai J-L, Somlo G, et al. Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma. Am J Clin Oncol. 2024.
2023
Ladbury C, Mei M, Kafaja S, Nall J, Han C, Dandapani S, Forman S, Wong JYc. Autologous Stem Cell Transplantation with Intensity Modulated Total Body Irradiation Conditioning for Systemic Sclerosis. Int J Radiat Oncol Biol Phys. 2023.
Hao C, Ladbury C, Wong J, Dandapani S. Modern Radiation for Hematologic Stem Cell Transplantation: Total Marrow and Lymphoid Irradiation or Intensity-Modulated Radiation Therapy Total Body Irradiation. Surg Oncol Clin N Am. 2023;32(3):475-495.
2022
Ladbury C, Somlo G, Dagis A, Yang D, Armenian S, Song JY, Sahebi F, Spielberger R, Popplewell L, Parker P, et al. Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow Irradiation. Transplant Cell Ther. 2022.
Ladbury C, Armenian S, Bosworth A, He T, F Wong L, Dandapani S, Han C, Liu A, Malki MAl, Rosenthal J, et al. Risk of subsequent malignant neoplasms following hematopoietic stem cell transplantation with total body irradiation or total marrow irradiation: insights from early follow-up. Transplant Cell Ther. 2022.